FDA Clearance Tracker · K171484
hema-screen SPECIFIC Gold
Last checked: Nov 20, 2026Latest source record: Jun 14, 2017 (this decision)Source: openFDAMethods & limitations
Decided
Jun 14, 2017
Substantially Equivalent
Time to decision
23 days
Received May 22, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K171484
- Device name
- hema-screen SPECIFIC Gold
- Applicant
- Immunostics Inc.,
- Applicant location
- Ocean, NJ
- Received
- May 22, 2017
- Decided
- Jun 14, 2017
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device type
- Reagent, Occult Blood (KHE)
- Device class
- Class II
- Regulation
- 21 CFR 864.6550
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code KHE. The earliest in FDA's data is K761232, decided Dec 21, 1976.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K171484
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Immunostics Inc.,
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K221817 · Decided Sep 22, 2023 · 457 days after receipt
Device type: System, Test, Vitamin D (MRG) · Laboratory Medicine & Pathology
- hemochroma PLUS System510(k)
K182298 · Decided Nov 16, 2018 · 84 days after receipt
Device type: System, Hemoglobin, Automated (GKR) · Laboratory Medicine & Pathology
- hemochroma PLUS System510(k)
K163465 · Decided Sep 8, 2017 · 270 days after receipt
Device type: System, Hemoglobin, Automated (GKR) · Laboratory Medicine & Pathology
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.